Compare Fox Corp Class A (FOXA) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class A vs Mesoblast Limited — how do they compare? Fox Corp Class A trades at $56.7 (market cap $22.28B), while Mesoblast Limited trades at $19.22 (market cap $2.31B). The key difference: Fox Corp Class A is far larger — about 9.6× Mesoblast Limited's market cap, and Fox Corp Class A pays a 1% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| FOXA | MESO | |
|---|---|---|
Market Cap | $22.28B | $2.31B |
Sector | Media | Technology |
52-Week High | $76.11 | $20.96 |
52-Week Low | $48.79 | $11.35 |
Enterprise Value | $26.25B | $2.32B |
Dividend Yield | 1% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fox Corporation (FOXA) trades at $55.94, up 1.95% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a P/E of 14.73 and net income margin of 10.56%, supported by $3.32B in operating cash flow for 2025. Recent news highlights the strategic $22B Roku acquisition, positioning Fox in the competitive streaming landscape.
The outlook is mixed: analyst consensus targets $67.80 (21% upside) with equal buy/hold ratings, but technicals and 2026 cash flow projections signal caution. Key risks include integration challenges from the Roku deal and advertising market volatility. The stock presents a value opportunity if execution risks are managed.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
